Skip to main content

Biventricular Pacing for Patients with Complete Heart Block

  • Chapter
  • First Online:
Clinical Controversies in Device Therapy for Cardiac Arrhythmias

Abstract

Complete heart block (CHB) is defined by the failure of atrial impulses to propagate through the conduction system to the ventricles. Pacemakers are indicated therapies for the treatment of nonreversible CHB, and traditionally this has been achieved with right ventricular (RV) transvenous devices. During the past two decades, biventricular pacing with a left ventricular (LV) pacing lead, or cardiac resynchronization therapy (CRT), has emerged as an alternative therapy with proven benefit in patients with heart failure due to systolic dysfunction and preexisting intraventricular conduction delay. Data are most clear to support a clinical benefit of CRT over traditional RV pacing (RVP) in patients with CHB and LVEF ≤35%, along with favorable data in patients with CHB and intermediate LVEF 36–49%. In patients with CHB and preserved LVEF ≥50%, there is less evidence to support the practice of de novo CRT over RVP. Other populations of interest include patients with congenital heart block and post-AV node ablation. In this comprehensive review, we provide a summary of the evidence for CRT versus traditional RVP in each of these subgroups and offer a suggested clinical approach to evaluating a patient with CHB for CRT.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vogler J, Breithardt G, Eckardt L. Bradyarrhythmias and conduction blocks. Rev Esp Cardiol (Engl Ed). 2012;65(7):656–67.

    Article  Google Scholar 

  2. Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, Goldschlager NF, Hamilton RM, Joglar JA, Kim RJ, Lee R, Marine JE, McLeod CJ, Oken KR, Patton KK, Pellegrini CN, Selzman KA, Thompson A, Varosy PD. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol. 2019.

    Google Scholar 

  3. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127(3):e283–352.

    Article  Google Scholar 

  4. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum. 2004;50(1):173–82.

    Article  CAS  Google Scholar 

  5. Baruteau AE, Pass RH, Thambo JB, et al. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr. 2016;175(9):1235–48.

    Article  CAS  Google Scholar 

  6. Ho SY, Esscher E, Anderson RH, Michaelsson M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol. 1986;58(3):291–4.

    Article  CAS  Google Scholar 

  7. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845–53.

    Article  Google Scholar 

  8. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.

    Article  CAS  Google Scholar 

  9. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–50.

    Article  CAS  Google Scholar 

  10. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–38.

    Article  Google Scholar 

  11. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363(25):2385–95.

    Article  CAS  Google Scholar 

  12. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834–43.

    Article  Google Scholar 

  13. Kindermann M, Hennen B, Jung J, Geisel J, Bohm M, Frohlig G. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol. 2006;47(10):1927–37.

    Article  Google Scholar 

  14. Martinelli Filho M, de Siqueira SF, Costa R, et al. Conventional versus biventricular pacing in heart failure and bradyarrhythmia: the COMBAT study. J Card Fail. 2010;16(4):293–300.

    Article  Google Scholar 

  15. Shimano M, Tsuji Y, Yoshida Y, et al. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with long-term pacemaker therapy for acquired complete atrioventricular block. Europace. 2007;9(10):869–74.

    Article  Google Scholar 

  16. Yu CM, Chan JY, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med. 2009;361(22):2123–34.

    Article  Google Scholar 

  17. Chan JY, Fang F, Zhang Q, et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J. 2011;32(20):2533–40.

    Article  Google Scholar 

  18. Stockburger M, Gomez-Doblas JJ, Lamas G, et al. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF). Eur J Heart Fail. 2011;13(6):633–41.

    Article  Google Scholar 

  19. Funck RC, Blanc JJ, Mueller HH, et al. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the ‘Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)’ study. Europace. 2006;8(8):629–35.

    Article  Google Scholar 

  20. Funck RC, Mueller HH, Lunati M, et al. Characteristics of a large sample of candidates for permanent ventricular pacing included in the Biventricular Pacing for Atrio-ventricular Block to Prevent Cardiac Desynchronization Study (BioPace). Europace. 2014;16(3):354–62.

    Article  Google Scholar 

  21. Merchant FM, Hoskins MH, Musat DL, et al. Incidence and time course for developing heart failure with high-burden right ventricular pacing. Circ Cardiovasc Qual Outcomes. 2017;10(6):1–11.

    Google Scholar 

  22. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol. 2005;16(11):1160–5.

    Article  Google Scholar 

  23. Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013;368(17):1585–93.

    Article  CAS  Google Scholar 

  24. Janousek J, van Geldorp IE, Krupickova S, et al. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study. Circulation. 2013;127(5):613–23.

    Article  Google Scholar 

  25. Motonaga KS, Dubin AM. Cardiac resynchronization therapy for pediatric patients with heart failure and congenital heart disease: a reappraisal of results. Circulation. 2014;129(18):1879–91.

    Article  Google Scholar 

  26. Mittal S, Musat DL, Hoskins MH, et al. Clinical outcomes after ablation of the AV junction in 523 patients with atrial fibrillation: impact of cardiac resynchronization therapy. J Am Heart Assoc. 2017;6(12):1–12.

    Google Scholar 

  27. Brignole M, Botto G, Mont L, et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J. 2011;32(19):2420–9.

    Article  Google Scholar 

  28. Nahlawi M, Waligora M, Spies SM, Bonow RO, Kadish AH, Goldberger JJ. Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol. 2004;44(9):1883–8.

    Article  Google Scholar 

  29. Kiehl EL, Makki T, Kumar R, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm. 2016;13(12):2272–8.

    Article  Google Scholar 

  30. Prinzen FW, Peschar M. Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol. 2002;25(4 Pt 1):484–98.

    Article  Google Scholar 

  31. Delhaas T, Arts T, Prinzen FW, Reneman RS. Regional fibre stress-fibre strain area as an estimate of regional blood flow and oxygen demand in the canine heart. J Physiol. 1994;477(Pt 3):481–96.

    Article  Google Scholar 

  32. Lee MA, Dae MW, Langberg JJ, et al. Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol. 1994;24(1):225–32.

    Article  CAS  Google Scholar 

  33. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med. 2011;154(6):401–12.

    Article  Google Scholar 

  34. European Heart Rhythm A, European Society of C, Heart Rhythm S, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm. 2012;9(9):1524–76.

    Article  Google Scholar 

  35. Zanon F, Ellenbogen KA, Dandamudi G, et al. Permanent his-bundle pacing: a systematic literature review and meta-analysis. Europace. 2018;20:1819–26.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roderick Tung .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wey, H.E., Upadhyay, G.A., Tung, R. (2019). Biventricular Pacing for Patients with Complete Heart Block. In: Steinberg, J., Epstein, A. (eds) Clinical Controversies in Device Therapy for Cardiac Arrhythmias . Springer, Cham. https://doi.org/10.1007/978-3-030-22882-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22882-8_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22881-1

  • Online ISBN: 978-3-030-22882-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics